drugset / Trial / NCT02946047
The Effect of Ixazomib on the Latent HIV Reservoir
Non-randomizedSequentialOpen-labelTreatment
Summary
The primary purpose of the trial is to determine the safety and tolerability of ixazomib in HIV infected patients on antiretroviral therapy. The secondary purpose is to determine the effect of ixazomib on the size of the HIV reservoir.
Timeline
- Start
- 2017-03-20
- Primary completion
- 2019-08-19
- Completion
- 2019-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixazomib | Unknown | 1 mg | — |
| Subject | Ixazomib | Unknown | 2 mg | — |
| Subject | Ixazomib | Unknown | 3 mg | — |
| Subject | Ixazomib | Unknown | 4 mg | — |